key: cord-0839594-bymw0mxv
authors: Song, Juan-Juan; Yang, Mei; Liu, Ying; Song, Jia-Wei; Wang, Juan; Chi, Hong-Jie; Liu, Xiao-Yan; Zuo, Kun; Yang, Xin-Chun; Zhong, Jiu-Chang
title: MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling
date: 2020-07-16
journal: Eur J Pharmacol
DOI: 10.1016/j.ejphar.2020.173374
sha: 693281a9cf19c5f039f4e62a812d3d24e286a0c7
doc_id: 839594
cord_uid: bymw0mxv

Abnormal aortic adventitial fibroblasts (AFs) play essential roles in the development of vascular remodeling and disorders. Previous studies revealed that microRNA-122 (miR-122) levels were elevated in the aortic adventitia of hypertensive rats with vascular injury. Here, we aim to evaluate the biological effects and underlying mechanisms of miR-122 in rat AFs. Exposure to angiotensin II (ATII) in rat AFs resulted in decreased levels of sirtuin 6 (SIRT6), elabela (ELA), and angiotensin-converting enzyme 2 (ACE2). Additionally, stimulation with ATII contributed to a decline in autophagic flux and an increase in cellular migration, oxidative stress, and apoptosis, which were exacerbated by the transfection of miR-122-5p mimic but were rescued by miR-122-5p inhibitor, exogenous replenishment of ELA, and recombinant adeno-associated virus expressing SIRT6 (rAAV-SIRT6). Moreover, stimulation with miR-122-5p mimic led to a marked reduction in the levels of SIRT6 and ELA in rat AFs, which were elevated by stimulation with rAAV-SIRT6. Furthermore, miR-122-5p inhibitor-mediated pro-autophagic, anti-oxidant and anti-apoptotic effects in rat AFs were partially suppressed by 3-methyladenine, SIRT6 small interfering RNA (siRNA) and ELA siRNA, which were linked with the downregulation in the protein levels of LC3-II, beclin-1, and ACE2 and the upregulation of p62 expression and bax/bcl-2 ratio. Our findings indicated that miR-122-5p inhibition prevented ATII-mediated loss of autophagy, and the promotion of apoptosis and oxidative stress via activating the SIRT6-ELA-ACE2 signaling. MiR-122-5p may be a novel predictive biomarker of adventitial injury, and targeting the SIRT6-ELA-ACE2 signaling may have the potential therapeutic importance of controlling vascular remodeling and disorders.

Eagle's medium supplemented with 20% heat-inactivated fetal bovine serum, 1% L-119 glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. The explants were 120 incubated in a humidified atmosphere of 5% CO 2 and 95% air at 37 °C until the cells Additionally, one cell plate was kept without dihydroethidium as a blank control.

Fluorescent images were captured with an Olympus IX51 microscope (Olympus, inhibitor rapamycin (Fig. 1C) . Intriguingly, ATII-mediated loss of autophagy was 247 further reduced by miR-122-5p mimic (Fig. 1C) , which was associated with lower 248 protein levels of beclin-1, LC3-II, and p-AMPK and higher expression of p62 and p-249 mTOR ( Fig. 1D and E) . Furthermore, the capability of cellular migration was 250 increased after stimulation with ATII, which was decreased by AICAR and rapamycin, 251 respectively ( Fig. 1F and G) . Conversely, ATII-induced pro-migratory action was 252 enhanced in rat AFs after the transfection of miR-122-5p mimic ( Fig. 1F and G).

Therefore, these findings demonstrated that miR-122-5p mimic accelerated ATII- 4B and D). Additionally, ATII-mediated loss of SIRT6 protein was rescued by SIRT6 310 overexpression ( Fig. 4E ) but was further reduced by SIRT6 siRNA (Fig. 4F ).

Moreover, both overexpression of SIRT6 and miR-122-5p inhibitor significantly 312 prevented the ATII-induced promotion of oxidative stress (Fig. 4G and H) , cellular 313 migration ( Fig. 4I and J) , and loss of autophagy (Fig. 4K) . Furthermore, the silencing interactions among miR-122-5p, SIRT6, and ELA in rat AFs. As expected, ATII-325 induced the downregulation of ELA expression was further reduced by miR-122-5p 326 mimic but was elevated by SIRT6 overexpression (Fig. 5A) . Intriguingly, treatment 327 with rAAV-SIRT6 rescued miR-122-5p mimic-mediated the decline in the expression 328 of ELA in response to ATII, suggesting that miR-122-5p negatively regulated ELA via 329 the suppression of SIRT6 signaling (Fig. 5A) . Then, we investigated the effects of ELA on ATII-mediated actions in rat AFs. Exogenous ELA stimulation inhibited ATII-331 mediated anti-autophagic action (Fig. 5B) , which was accompanied by the 332 upregulation of beclin-1 and LC3-II expression and the downregulation in the protein 333 level of p62 ( Fig. 5C and D) . However, the pro-autophagic role of ELA was partially 334 blocked by 3-methyladenine (Fig. 5B, C, and D) . Moreover, treatment with ELA 335 reduced bax/bcl-2 ratio (Fig. 5C and D) and prevented ATII-induced cellular apoptosis 336 ( Fig. 5E and F) and oxidative stress ( Fig. 5G and H) , which were enhanced by 3- The mRNA level of ELA (Fig. 6A ) and the expression of ACE2 (Fig. 6B , C, and D) 351 were significantly downregulated after the silencing of ELA and ACE2, respectively.

Moreover, treatment with miR-122-5p inhibitor suppressed ATII-mediated promotion 353 of cellular apoptosis ( Fig. 6E and F), oxidant injury ( Fig. 6G and H) , and 354 inflammatory response (Fig. 6I) , and loss of autophagy (Fig. 6J) , which were partially 355 reversed by co-transfection of ELA siRNA. Furthermore, stimulation with ATII 356 induced a marked decrease in the protein level of ACE2 in rat AFs, which was 357 elevated by the administration of ELA ( Fig. 6K and L) . Importantly, co-treatment with 358 ACE2 siRNA inhibited ELA-mediated the upregulation in the expression of ACE2 359 ( Fig. 6K and L) . Taken together, these data demonstrated that inhibition of miR-122-360 5p suppressed ATII-mediated pro-apoptotic, pro-oxidant, pro-inflammatory, and anti-361 autophagic effects by activating the SIRT6-ELA-ACE2 signaling in rat AFs (Fig. 7) . blots with quantification to examine the protein levels of caspase-3, bax, and bcl-2.

GAPDH was used as an endogenous control. n=3-4 for each group. **, P < 0.01

Characterization and functions of vascular adventitial 504 fibroblast subpopulations

Anti-inflammatory properties of sirtuin 6 in human umbilical vein 553 endothelial cells

MicroRNA-122 promotes endothelial cell apoptosis by 555 targeting XIAP: Therapeutic implication for atherosclerosis

The Elabela-APJ axis: a promising therapeutic for heart 558 failure

Modulation of inflammation by 560 autophagy: consequences for human disease

Role of the ACE2/Angiotensin 1-7 Axis of the

System in Heart Failure

MiR-122 regulates cell apoptosis and ROS by targeting 566 DJ-1 in renal ischemic reperfusion injury rat models

C-reactive protein and other markers of 570 inflammation in the prediction of cardiovascular disease in women

angiotensin II-induced apoptosis and oxidative stress by promoting the activation 595 of Nrf2/ARE signaling

The sirtuin 6 prevents angiotensin II-mediated 598 myocardial fibrosis and injury by targeting AMPK-ACE2 signaling

Apelin is a negative regulator of angiotensin II-601 mediated adverse myocardial remodeling and dysfunction

Angiotensin-converting enzyme 2 suppresses 604 pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction

##, P < 0.01 compared with ATII or 639 ATII+NC group

AICAR, 5-amino-4-641 imidazole carboxamide riboside

Rapa, rapamycin; NA, no statistical significance

Representative immunofluorescence images of 644 p62 (red) and LC3 (green) in response to ATII, NC, miR-122-5p inhibitor, 3-MA, 645 respectively. (B-C) Representative western blots with quantification to detect protein 646 levels of biomarkers of autophagy and apoptosis, respectively. (D-E) Flow cytometry 647 to examine cellular apoptosis. (F) Relative mRNA levels of IL-10, IL-18, and IL-33 648 with qRT-PCR analysis. (G-H) Representative dihydroethidium staining with 649 quantification to detect reactive oxygen species. GAPDH was used as an endogenous 650 control

05, ##, P<0.01 compared with ATII+NC group

relative expression; NC, 654 negative control; ATII, angiotensin II

3-MA, 3-655 methyladenine; IL-10, interleukin-10; IL-18, interleukin-18

Treatment with miR-122-5p inhibitor prevented ATII-mediated promotion 658 of oxidative stress, migration, and loss of autophagy in rat AFs. (A) The binding 659 sites between miR-122-5p and 3'-UTR of SIRT6 mRNA. (B) Relative mRNA level of

C-D) Western blots to examine protein levels of SIRT6 661 after the transfection of miR-122-5p mimic and inhibitor, respectively. (E-F) Protein 662 levels of SIRT6 after the overexpression and knockdown of SIRT6, respectively

Representative dihydroethidium staining images and relative fluorescence. (I-J) In 664 vitro wound healing to determine cellular migration at 0 h and 24 h

Representative immunofluorescence images of p62 (red) and LC3 (green) to examine 666 autophagic flux. GAPDH was used as an endogenous control. n=3-4 for each group 667 except for B where n=6

01 668 compared with ATII+NC or ATII+rAAV-GFP group

ATII+miR-122 inhibitor group. A.U., arbitrary units; R.E., relative expression; ATII, 670 angiotensin II; AFs

The relative mRNA level of ELA was 673 downregulated by miR-122-5p mimic but was upregulated with rAAV-SIRT6 674 treatment. (B) Representative immunofluorescence images of p62 (red) and LC3 675 (green) to examine autophagic flux. (C-D) Representative western blots to determine 676 the levels of p62, beclin-1, LC3, bax, and bcl-2. GAPDH was used as an endogenous 677 control

Dihydroethidium staining to examine reactive oxygen species generation. n=3-4 for 679 each group except for A where n=6. **, P < 0.01 compared with control group; ##, P 680 < 0.01 compared with ATII or ATII+NC or ATII+ rAAV-GFP group

01 compared with ATII+ELA group

relative expression; ATII, 683 angiotensin II; AFs, adventitial fibroblasts; 3-MA, 3-methyladenine; NC, negative 684 control

Inhibition of miR-122-5p exerted the protective effects on ATII-mediated 686 pro-apoptosis, pro-oxidant, pro-inflammation, and anti-autophagy via regulating 687 the ELA-ACE2 signaling in rat AFs. (A) The relative mRNA level of ELA was 688 downregulated after the knockdown of ELA. (B-D) Decreased mRNA and protein 689 levels of ACE2 were performed to ensure the effective transfection of ACE2 siRNA

E-F) Percentage of apoptotic cells by flow cytometry analysis. (G-H) The production 691 of oxidative stress by dihydroethidium staining. (I) Relative mRNA levels of IL-10

IL-18, and IL-33. (J) Immunofluorescence images of p62 (red) and LC3 (green) to 693 examine autophagic flux. (K-L) The expression of ACE2 in the presence of ATII

ELA, and ACE2 siRNA, respectively. GAPDH was used as an endogenous control

n=3-4 for each group except for I where n=5-6. *, P < 0.05, **, P < 0.01 compared 696 with control or NC siRNA group

01 compared with ATII+ELA+NC siRNA group ; $, P < 0.05, $$, P < 0.01 698 compared with ATII+miR-122 inhibitor+ NC siRNA group. A.U., arbitrary units

Schematic overview of the crucial roles of miR-122-5p in rat aortic 703 adventitial fibroblasts. MiR-122-5p serves as an important regulator of

apoptosis, oxidative stress, and inflammation in rat adventitial 705 fibroblasts by modulating the SIRT6-Elabela-ACE2 signaling

MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-Elabela-ACE2 signaling

MiR-122-5p inhibitor prevents angiotensin II-mediated loss of SIRT6 and autophagy and promotion of apoptosis

Treatment with rAAV-SIRT6 inhibits miR-122-5p mimic-mediated loss of ELA and autophagy and promotion of apoptosis

MiR-122-5p inhibitor-induced beneficial roles in autophagy and apoptosis are suppressed by ELA siRNA

MiR-122-5p exerts pro-apoptotic and anti-autophagic effects via the modulation of SIRT6-Elabela-ACE2 signaling